⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10821968 | 0.73 | — | — | |
| SCHEMBL3753850 | 0.73 | TSHR (0.42) | — | |
| SCHEMBL5567532 | 0.73 | — | — | |
| SCHEMBL22928680 | 0.72 | THRB (0.40) | — | |
| SCHEMBL10198688 | 0.71 | — | — | |
| SCHEMBL9407525 | 0.71 | TSHR (0.33) | — | |
| SCHEMBL1196363 | 0.71 | — | — | |
| SCHEMBL605994 | 0.71 | — | — | |
| SCHEMBL14692094 | 0.71 | — | — | |
| SCHEMBL7817161 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024015262-A1 | FUSED RING KRAS INHIBITORS FOR TREATING DISEASE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2024-01-18 | — | — | WO | disclosed |
| US-9994547-B2 | Heteroarylamide inhibitors of TBK1 | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-06-12 | — | — | US | disclosed |
| US-20170313675-A1 | HETEROARYLAMIDE INHIBITORS OF TBK1 | TAKEDA CALIFORNIA, INC. | 2017-11-02 | — | — | US | disclosed |
| WO-2016057338-A1 | HETEROARYLAMIDE INHIBITORS OF TBK1 | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-04-14 | — | — | WO | disclosed |
| WO-2012172093-A1 | DIHYDROINDOLIZINE DERIVATE AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2012-12-20 | — | — | WO | disclosed |
| US-20120231297-A1 | LUBRICANT COMPOSITION, FLUORINE-BASED COMPOUND, AND USE THEREOF | FUJIFILM CORPORATION (JP) | 2012-09-13 | — | — | US | disclosed |
| EP-1463506-B1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES | ASTRAZENECA AB (SE) | 2009-10-21 | — | — | EP | disclosed |
| US-20090215770-A1 | Substituted Quinazoline Derivatives as Inhibitors of Aurora Kinases | ASTRAZENECA AB (SE) | 2009-08-27 | — | — | US | disclosed |
| US-7402585-B2 | Substituted quinazoline derivatives as inhibitors of aurora kinases | ASTRAZENECA AB (SE) | 2008-07-22 | — | — | US | disclosed |
| US-20050070561-A1 | Substituted quinazoline derivatives as inhibitors of aurora kinases | ASTRAZENECA AB (SE) | 2005-03-31 | — | — | US | disclosed |
| EP-1463506-A1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES | Astrazeneca AB (SE) | 2004-10-06 | — | — | EP | disclosed |
| WO-2003055491-A1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES | ASTRAZENECA AB (SE) | 2003-07-10 | — | — | WO | disclosed |